Connect with us

Hi, what are you looking for?

OMD NewsOMD News


The global threat of mosquito-borne illness is addressed by Island Pharmaceuticals’ adaptation of existing medication.

Photo from Google

Island Pharmaceuticals Ltd. is repurposing a known medicine to address the global health crisis of mosquito-borne diseases like dengue fever.

Photo from Google

Island Pharmaceuticals Repurposes Drug for Global Mosquito-Borne Disease Threat

Dengue illness affects 390 million people annually, causing concern. The fact that 30-50% of infected people have no symptoms makes the virus spread quietly throughout communities. Due to a rising global environment, mosquito-borne viruses may spread to the US, Europe, and Australia.

The only dengue fever vaccine is offered to a limited population, and there are no medicinal therapies. This needs effective treatments. Island Pharmaceuticals Ltd., an infectious disease drug development and repurposing business, is leading this effort.

ISLA-101, Island Pharmaceuticals’ key asset, is being repurposed in a novel way. The company’s affiliate Isla Pharmaceuticals created ISLA-101, which has a strong clinical and safety record. The medicine is being re-engineered as an anti-viral to prevent and cure dengue and other mosquito- and vector-borne infections.

READ ALSO: Life-Saving Apple Watch Feature Rescues Woman From Almost Deadly Carbon Monoxide Exposure: ‘I Was Terrified

ISLA-101: Island Pharmaceuticals’ Innovative Approach to Combatting Mosquito-Borne Viruses

ISLA-101’s unique method targets viral-host protein interaction, a common mosquito-borne virus route. Beyond dengue fever, Island Pharmaceuticals wants to explore ISLA-101 in Phase 2 clinical trials as a broad-spectrum prevention or treatment for Zika, Yellow River Fever, Japanese Encephalitis, and West Nile virus.

Island Pharmaceuticals’ repurposing business strategy accelerates ISLA-101’s clinical application by using existing data and safety profiles. This method cuts development time and costs and navigates the regulatory landscape utilizing existing data. Island Pharmaceuticals is helping fight mosquito-borne infections worldwide by repurposing ISLA-101. The company’s cost-effective and creative pipeline could change world health.

READ ALSO: Epstein-Barr Virus T-Cells Abundant In Initial Stages Of Multiple Sclerosis, Reveals Research

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


There is finally an update on 4th stimulus check for Social Security Recipients! Individuals who receive Social Security benefits can expect to receive a...


The attack using 14 military choppers that Russian President Vladimir Putin planned was destroyed by Ukraine using US-supplied long-range tactical missiles. Russian President Vladimir...


The Biden administration has announced recently that it plans to increase the monthly payments of seniors and veterans to $2,000. $2,000 in Monthly Payments...


In Texas, this September the SNAP payments will end, worth up to $1,691, on Friday. The household income determines eligibility. A single-person household must earn more than...